Shenfu Injection Modulates Carotid Elasticity in Septic Shock

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Septic ShockVascular DysfunctionArterial StiffnessCarotid Artery Elasticity AlterationsSepsis
Interventions
DRUG

Shenfu Injection

"This intervention combines traditional Chinese medicine (TCM) with modern critical care practices to distinguish it from conventional sepsis therapies. Key unique features include:~TCM-Based Intervention:~Shenfu Injection: A standardized herbal extract derived from Panax ginseng and Aconitum carmichaelii , prepared under Chinese Pharmacopoeia guidelines.~Mechanism: Targets mitochondrial dysfunction and endothelial glycocalyx repair, with preclinical evidence of anti-inflammatory, anti-apoptotic, and vasoregulatory effects.~Precision Delivery Protocol:~Dosage: 60 mL (1 mL/kg for patients \<60 kg) administered via syringe pump-controlled continuous infusion over 3 hours, ensuring stable plasma concentrations.~Timing: Initiated only after hemodynamic stabilization (≥1 hour of stable vasopressor requirements post-fluid resuscitation), aligning with the golden window for vascular repair in sepsis."

Trial Locations (1)

241000

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu

All Listed Sponsors
collaborator

Wuhu City Second People's Hospital

OTHER

lead

First Affiliated Hospital of Wannan Medical College

OTHER